Therapeutic potential of ERK5 targeting in triple negative breast cancerMaría Jesús Ortiz-Ruiz, Azucena Esparı́s-Ogando|Oncotarget|2014Cited by 48
Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancerAdrián Sánchez‐Fdez, Azucena Esparı́s-Ogando|npj Precision Oncology|2021Cited by 31
The WNK1–ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinibAdrián Sánchez‐Fdez, Azucena Esparı́s-Ogando|Clinical and Translational Medicine|2023Cited by 11
The nicotinic receptors in the nervous systemCecilia Gotti, F. Clementi, Diego Fornasari et al.|Pharmacological Research Communications|1988Cited by 10
α-Bungarotoxin Receptor in a Human Neuroblastoma Cell LineCecilia Gotti, F. Clementi, Emanuele Sher et al.|Unknown|1988Cited by 2